How Much Did Palliare Raise?
Funding & Key Investors

Palliare, a medical device company focused on advancing smoke evacuation and insufflation technologies, has secured $8M in a major strategic investment, contributing to its total funding of $8M. This recent capital infusion, categorized as a major enterprise-level funding round, underscores the company's progress and market potential in surgical innovation.

What is Palliare?

Palliare
ManufacturingMedical Devices & Equipment

Palliare operates at the forefront of medical technology, specializing in the development of sophisticated smoke evacuation and insufflation systems. These technologies are critical for enhancing safety and efficiency in a range of minimally invasive surgical procedures, including laparoscopic, endoluminal, endoscopic, and robotic surgery. Based in Oceanside, California, the company is dedicated to pushing the boundaries of what's possible in surgical instrumentation, aiming to improve patient outcomes and surgeon experience.

How much funding has Palliare raised?

Palliare has raised a total of $8M across 1 funding round:

2021

Series A

$8M

Series A (2021): $8M with participation from Western Development Commission, SCM AD Ventures, and Seroba Life Sciences Management

Key Investors in Palliare

Seroba Life Sciences Management

Seroba Life Sciences Management is a European venture capital firm with a strong focus on investing in innovative biotech and medtech companies. Their deep industry expertise supports entrepreneurs in realizing ambitious goals and creating value.

Western Development Commission

Western Development Commission is an entity that participated in Palliare's funding round, contributing to the company's strategic growth initiatives.

SCM AD Ventures

SCM AD Ventures is an investment firm that has backed Palliare, indicating a belief in the company's technological advancements and market potential.

What's next for Palliare?

The recent major strategic investment signifies a pivotal moment for Palliare, likely enabling the company to accelerate its product development pipeline, scale manufacturing capabilities, and expand its market reach. This Series A financing, following a significant funding event, positions Palliare for substantial growth. The company is expected to leverage this capital to further solidify its position in the competitive medical device sector, potentially exploring new applications for its core technologies and strengthening its commercialization efforts.

See full Palliare company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingToys & GamesRetail
Building MaterialsManufacturingConstruction ManagementConstruction
Industrial Machinery & EquipmentManufacturingRetailOther Rental Stores (Furniture, A/V, Construction & Industrial Equipment)
ManufacturingPlastic, Packaging & Containers

Frequently Asked Questions Regarding Palliare Financial Insights

What are the most recent funding rounds that Palliare has completed, and what were the funding rounds?
Palliare has recently completed 1 funding rounds: Series A on Jun 28, 2021.
What is the total amount of funding Palliare has raised to date?
Palliare has raised a total of $8M in funding to date.
How many funding rounds has Palliare completed?
Palliare has completed 1 funding rounds.
How much funding did Palliare raise in its most recent funding round?
Palliare raised $8M in its most recent funding round.
Who are the lead investors in Palliare's latest funding round?
The lead investor in Palliare's latest funding round was Western Development Commission. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Palliare's history?
The largest funding round in Palliare's history was $8M.
See more information about Palliare